Robert Hadfield's most recent trade in Alaunos Therapeutics Inc was a trade of 326,250 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 4, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alaunos Therapeutics Inc | Robert Hadfield | Chief Legal Officer and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 326,250 | 326,250 | - | - | Employee Stock Option (right to buy) | |
Alaunos Therapeutics Inc | Robert Hadfield | Chief Legal Officer and Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 43,500 | 176,819 (0%) | 0% | 0 | Common Stock | |
Alaunos Therapeutics Inc | Robert Hadfield | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 08 Jan 2021 | 26,500 | 133,319 (0%) | 0% | 3.1 | 82,680 | Common Stock |